ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
프로류킨 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 진행성 암에 대한 효과적인 치료에 대한 수요 증가, 희귀암에 대한 첨단 치료에 대한 수요 증가, 프로류킨의 효능을 뒷받침하는 임상적 증거의 증가, 면역 종양 치료에 대한 의료 기관의 지원 증가, 암 환자 수의 증가에 기인할 수 있습니다. 예측 기간 동안의 주요 동향으로는 생물학적 치료의 발전, 프로류킨을 사용한 병용 요법의 개발, 기술 발전, 전략적 협력 및 파트너십, 암 백신 개발의 발전 등이 있습니다.
암 질환의 증가는 앞으로 프로류킨 시장의 성장을 촉진할 것으로 예상됩니다. 암은 비정상적인 세포가 통제되지 않고 증식 및 확산되어 주변 조직을 침범하고 다른 신체 부위로 전이될 수 있는 질병의 총칭입니다. 암의 유병률 증가는 인구 고령화, 진단 방법의 발전, 생활 습관의 변화, 환경 노출 및 생존율의 향상으로 촉진되고 있습니다. 프로류킨은 고용량 인터루킨-2 치료제로, 면역 시스템을 자극하여 암 세포를 표적화하고 파괴함으로써 전이성 흑색종 및 신세포 암과 같은 진행성 암의 잠재적 치료법을 제공합니다. 예를 들어, 2024년 2월 세계보건기구(WHO)는 2022년 약 2,000만 건의 신규 암 사례를 보고했으며, 2050년까지 3,500만 건 이상의 신규 사례가 발생할 것으로 전망되었습니다. 따라서 암 질환의 증가가 프로류킨 시장의 성장을 촉진하고 있습니다.
연구 개발 활동의 증가는 앞으로 프로류킨 시장의 성장을 촉진할 것으로 예상됩니다. 연구 개발(R&D)은 혁신적인 제품을 만들고, 기존 제품을 개선하며, 새로운 솔루션을 개발하기 위한 과학적 노력을 의미합니다. 기술 발전에 대한 수요와 전 세계적으로 새로운 과제를 해결해야 할 필요성으로 인해 연구 개발 활동이 증가하고 있습니다. 제약 산업에서의 R&D 증가는 프로류킨의 효능 향상, 새로운 암 적응증 탐색, 투여 방법 개선, 부작용 감소 등을 통해 임상적 적용 범위를 확대합니다. 예를 들어, 2024년 7월 보건복지부는 영국이 2022년에 제약 R&D에 113억 달러를 지출했다고 보고했습니다. 따라서 연구 개발 활동의 증가는 프로류킨 시장의 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 프로류킨 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계 프로류킨 시장 : 성장률 분석
세계의 프로류킨 시장 실적 : 규모와 성장(2019-2024년)
세계의 프로류킨 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 프로류킨 : 전체 시장 규모(TAM)
제7장 세계 시장의 가격 분석과 예측
제8장 시장 세분화
세계의 프로류킨 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
주사제
분말
기타
세계의 프로류킨 시장 : 치유 영역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
종양학
면역학
기타 치료 영역
세계의 프로류킨 시장 : 질환별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
전이성 신세포암(RCC)
비소세포폐암(NSCLC)
기타
세계의 프로류킨 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
약국
세계의 프로류킨 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
성인
소아과
제9장 임상적응증 세계 시장 역학
약제의 부작용
임상적응증의 발병률과 유병률
제10장 지역별, 국가별 분석
세계의 프로류킨 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 프로류킨 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 프로파일
프로류킨 시장 : 경쟁 구도
프로류킨 시장 : 기업 프로파일
Novartis Pharmaceuticals Corporation
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 전략
프로류킨 시장(2029년) : 새로운 기회를 제공하는 국가
프로류킨 시장(2029년) : 새로운 기회를 제공하는 부문
프로류킨 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
HBR
영문 목차
영문목차
Proleukin is the brand name for aldesleukin, a recombinant form of interleukin-2 (IL-2), a naturally occurring protein in the body. As a biologic therapy, Proleukin is primarily used in oncology and immunotherapy. It works by stimulating the growth and activity of specific white blood cells (lymphocytes), boosting the immune system's ability to identify and target cancer cells.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main formulations of proleukin include injection, powder, and others. Proleukin injection is a liquid form of aldesleukin, a recombinant interleukin-2, used for immune system modulation. It is indicated for various clinical conditions, including metastatic renal cell carcinoma (RCC), non-small cell lung cancer (NSCLC), and other therapeutic areas in oncology, immunology, and beyond. Proleukin is distributed through both online and offline channels and is used in hospitals and pharmacies for both adult and pediatric patients.
The proleukin market research report is one of a series of new reports from The Business Research Company that provides proleukin market statistics, including proleukin industry global market size, regional shares, competitors with a proleukin market share, detailed proleukin market segments, market trends and opportunities, and any further data you may need to thrive in the proleukin industry. This proleukin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The proleukin market size is expected to see strong growth in the next few years. It will grow to $1,581.3 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rising demand for effective treatments in advanced cancer stages, growing demand for advanced treatments for rare cancers, growing clinical evidence supporting proleukin's efficacy, increasing support from healthcare organizations for immuno-oncology treatments, increasing number of cancer patients. Major trends in the forecast period include advancements in biologic therapies, development of combination therapies using proleukin, technological advancements, strategic collaborations and partnerships, advancements in cancer vaccine development.
The growing cancer disease is expected to drive the growth of the proleukin market going forward. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells, which can invade surrounding tissues and metastasize to other body parts. The increasing prevalence of cancer is driven by an aging population, improved detection methods, lifestyle changes, environmental exposures, and better survival rates. Proleukin, a high-dose interleukin-2 therapy, stimulates the immune system to target and destroy cancer cells, offering potential treatment for advanced cancers such as metastatic melanoma and renal cell carcinoma. For instance, in February 2024, the World Health Organization reported an estimated 20 million new cancer cases in 2022, with projections indicating over 35 million new cases by 2050. Therefore, the growing cancer disease is driving the growth of the Proleukin market.
The increasing research and development activities are expected to drive the growth of the proleukin market going forward. Research and development (R&D) involves scientific efforts to create innovative products, improve existing ones, and develop new solutions. R&D activities are rising due to the demand for technological advancements and the need to address emerging global challenges. Increased R&D in the pharmaceutical industry contributes to enhancing Proleukin's efficacy, exploring new cancer indications, improving delivery methods, and reducing side effects, which expands its clinical use. For example, in July 2024, the Department of Health and Social Care reported that the UK spent $11.3 billion on pharmaceutical R&D in 2022. Therefore, the increasing research and development activities are driving the growth of the Proleukin market.
In May 2023, Iovance Biotherapeutics, a US-based biotechnology company focused on T-cell-based cancer immunotherapies, acquired Proleukin (aldesleukin) from Clinigen Limited for an undisclosed amount. This acquisition allows Iovance to enhance its T-cell-based cancer immunotherapy platform by integrating Proleukin, a key immunotherapy agent. By incorporating Proleukin into its tumor-infiltrating lymphocyte (TIL) therapies, Iovance aims to improve the effectiveness of these therapies and further advance its pipeline of innovative cancer treatments. This acquisition strengthens Iovance's position in the competitive oncology market. Clinigen Group, a UK-based company, was the previous provider of Proleukin (aldesleukin).
Key player operating in the proleukin market is Novartis Pharmaceuticals Corporation
North America was the largest region in the proleukin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proleukin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the proleukin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The proleukin market consists of sales of cancer vaccines, biosimilars, immune checkpoint inhibitors and adjuvants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Proleukin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on proleukin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for proleukin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The proleukin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Injection; Powder; Other Types
2) By Therapeutic Area: Oncology; Immunology; Other Therapeutic Areas
3) By Clinical Indication: Metastatic Renal Cell Carcinoma (RCC); Non-Small Cell Lung Cancer (NSCLC); Other Indications
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Proleukin Market Characteristics
3. Proleukin Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Proleukin Market Trends And Strategies
5. Proleukin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Proleukin Growth Analysis And Strategic Analysis Framework
6.1. Global Proleukin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Proleukin Market Growth Rate Analysis
6.4. Global Proleukin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Proleukin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Proleukin Total Addressable Market (TAM)
7. Global Proleukin Market Pricing Analysis & Forecasts
8. Proleukin Market Segmentation
8.1. Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection
Powder
Other Types
8.2. Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Immunology
Other Therapeutic Areas
8.3. Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metastatic Renal Cell Carcinoma (RCC)
Non-Small Cell Lung Cancer (NSCLC)
Other Indications
8.4. Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Pharmacy
8.5. Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adults
Pediatrics
9. Global Proleukin Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Proleukin Market Regional And Country Analysis
10.1. Global Proleukin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Proleukin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Proleukin Market
11.1. Asia-Pacific Proleukin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Proleukin Market
12.1. China Proleukin Market Overview
12.2. China Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Proleukin Market
13.1. India Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Proleukin Market
14.1. Japan Proleukin Market Overview
14.2. Japan Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Proleukin Market
15.1. Australia Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Proleukin Market
16.1. South Korea Proleukin Market Overview
16.2. South Korea Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Proleukin Market
17.1. Western Europe Proleukin Market Overview
17.2. Western Europe Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Proleukin Market
18.1. UK Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Proleukin Market
19.1. Germany Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Proleukin Market
20.1. France Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Proleukin Market
21.1. Eastern Europe Proleukin Market Overview
21.2. Eastern Europe Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Proleukin Market
22.1. North America Proleukin Market Overview
22.2. North America Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Proleukin Market
23.1. USA Proleukin Market Overview
23.2. USA Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Proleukin Market
24.1. Canada Proleukin Market Overview
24.2. Canada Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Proleukin Market
25.1. South America Proleukin Market Overview
25.2. South America Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Proleukin Market
26.1. Middle East Proleukin Market Overview
26.2. Middle East Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Proleukin Market
27.1. Africa Proleukin Market Overview
27.2. Africa Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Proleukin Market Competitive Landscape And Company Profiles
28.1. Proleukin Market Competitive Landscape
28.2. Proleukin Market Company Profiles
28.2.1. Novartis Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis
29. Global Proleukin Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Proleukin Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Proleukin Market
32. Recent Developments In The Proleukin Market
33. Proleukin Market High Potential Countries, Segments and Strategies
33.1 Proleukin Market In 2029 - Countries Offering Most New Opportunities
33.2 Proleukin Market In 2029 - Segments Offering Most New Opportunities
